Press Releases from Panacea Biotec (2 total)
Panacea Biotec announces successful completion of Phase I/II study of its novel, …
• DengiAll induced robust, balanced neutralizing antibody responses against all the four Dengue virus serotypes.
• DengiAll has been found to be safe and well-tolerated with no serious…
Panacea Biotec and Refana announce landmark collaboration for Covid-19 vaccine
Panacea Biotec is advancing its response to address the unprecedented challenges of COVID-19 by collaborating with Refana Inc. USA to make candidate Covid-19 vaccine widely…
Go To Page:
